Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Pont

Showing results (111-120 of 131) with videos related to

Pageof 14
Sort By:
Haematologica|June 13, 2015
LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic applicationMargot J Pont, Willemijn Hobo, Maria W Honders, et al.
Frontiers in Immunology|May 5, 2020
Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility AntigensKyra J Fuchs, M Willy Honders, Edith D van der Meijden, et al.
Children (Basel, Switzerland)|May 27, 2023
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and AdolescentsSarah E Messiah, Michael D Swartz, Rhiana A Abbas, et al.
Leukemia Research|January 1, 1997
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II studyJ Thaler, W Hilbe, U Apfelbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.
Blood|September 28, 2019
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myelomaMargot J Pont, Tyler Hill, Gabriel O Cole, et al.
Pediatric Research|October 24, 2023
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescentsSarah E Messiah, Yashar Talebi, Michael D Swartz, et al.
The Pediatric Infectious Disease Journal|August 8, 2022
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and AdolescentsSarah E Messiah, Tianyao Hao, Stacia M DeSantis, et al.
Leukemia Research|March 7, 2003
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)T Kühr, S Burgstaller, U Apfelbeck, et al.
Plos One|May 13, 2016
Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological MalignanciesM J Pont, M W Honders, A N Kremer, et al.
Pageof 14

Showing results (111-120 of 131) with videos related to

Sort By:
Pageof 14
Haematologica|June 13, 2015
LB-ARHGDIB-1R as a novel minor histocompatibility antigen for therapeutic applicationMargot J Pont, Willemijn Hobo, Maria W Honders, et al.
Frontiers in Immunology|May 5, 2020
Optimized Whole Genome Association Scanning for Discovery of HLA Class I-Restricted Minor Histocompatibility AntigensKyra J Fuchs, M Willy Honders, Edith D van der Meijden, et al.
Children (Basel, Switzerland)|May 27, 2023
SARS-CoV-2 Serostatus and COVID-19 Illness Characteristics by Variant Time Period in Non-Hospitalized Children and AdolescentsSarah E Messiah, Michael D Swartz, Rhiana A Abbas, et al.
Leukemia Research|January 1, 1997
Interferon-alpha-2C and LD ara-C for the treatment of patients with CML: results of the Austrian multi-center phase II studyJ Thaler, W Hilbe, U Apfelbeck, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2016
Integrated Whole Genome and Transcriptome Analysis Identified a Therapeutic Minor Histocompatibility Antigen in a Splice Variant of ITGB2Margot J Pont, Dyantha I van der Lee, Edith D van der Meijden, et al.
Blood|September 28, 2019
γ-Secretase inhibition increases efficacy of BCMA-specific chimeric antigen receptor T cells in multiple myelomaMargot J Pont, Tyler Hill, Gabriel O Cole, et al.
Pediatric Research|October 24, 2023
Long-term immune response to SARS-CoV-2 infection and vaccination in children and adolescentsSarah E Messiah, Yashar Talebi, Michael D Swartz, et al.
The Pediatric Infectious Disease Journal|August 8, 2022
Comparison of Persistent Symptoms Following SARS-CoV-2 Infection by Antibody Status in Nonhospitalized Children and AdolescentsSarah E Messiah, Tianyao Hao, Stacia M DeSantis, et al.
Leukemia Research|March 7, 2003
A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML)T Kühr, S Burgstaller, U Apfelbeck, et al.
Plos One|May 13, 2016
Microarray Gene Expression Analysis to Evaluate Cell Type Specific Expression of Targets Relevant for Immunotherapy of Hematological MalignanciesM J Pont, M W Honders, A N Kremer, et al.
Pageof 14